The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study

Not Applicable

• Conditions: Rheumatoid Arthritis
• Interventions: Other: MRI

• Registration Number: NCT01050010
• Lead Sponsor: Centre Hospitalier Universitaire de Nice

Brief Summary

The major aim of treatment for rheumatoid arthritis is remission. Nevertheless, structural radiographic progression is observed in 15 to 20% of patient getting remission. Numerous definitions of the remission proposed by literature remain imperfect.

Recently ultrasonography and MRI seem to be helpful in diagnosis and follow-up of rheumatoid arthritis.

Studies in patients with clinical remission are reporting 75 to 90% of persistent MRI and ultrasonography synovitis, 45% of cases with synovial activity.

To our knowledge, in such case few studies showed correlation between persistent imaging synovitis and structural radiographic progression.

On the other hand, no studies with extremity dedicated RMI in patients with remission are reported.

In this preliminary study, the investigators propose to evaluate in patients with rheumatoid arthritis remission and persistent dedicated MRI synovitis the structural radiographic progression at one year.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-01-14
• Study First Submitted QC: 2010-01-14
• Study First Posted: 2010-01-15
• Study Start: 2010-04
• Primary Completion: 2010-04
• Status Verified: 2011-12
• Last Update Submitted: 2011-12-08
• Last Update Posted: 2011-12-09
• Study Completion: 2012-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Earlier rheumatoid arthritis (<1 year)
• Clinical remission (DAS 28 <2,6 ou SDAI <5) since 6 months before the inclusion
• Unchanged DMARds and /or biologic therapy since 6 months before the inclusion
• Unchanged corticosteroid (5 mg/day) since 3 months before the inclusion in patients treated with this therapy
• No contre-indication to the MRI

Exclusion Criteria

• Contra-indication to MRI
• Pregnant or breast-feeding women

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Dedicated extremity MRI	MRI	Structural deterioration radiographic assessed by dedicated extremity MRI

Primary Outcome Measures

Name	Time	Method
Dedicated extremity MRI (hand and wrist)/ X-Ray (hand, wrist and foot)	at Month 0 (first visit) and Month 12 (last visit)

Secondary Outcome Measures

Name	Time	Method
Ultrasonography (hand, wrist and foot)	at Month 0 (first vist) and Month 12 (last visit)

Trial Locations

Locations (2)

Rheumatology Department, Nice University Hospital; 🇫🇷 Nice, France

CHU de NICE; 🇫🇷 Nice, France